How big is the South & Central America Feed Anticoccidials Market?

The South & Central America Feed Anticoccidials Market is valued at US$ 176.63 Million in 2023, it is projected to reach US$ 245.71 Million by 2031.

What is the CAGR for South & Central America Feed Anticoccidials Market by (2023 - 2031)?

As per our report South & Central America Feed Anticoccidials Market, the market size is valued at US$ 176.63 Million in 2023, projecting it to reach US$ 245.71 Million by 2031. This translates to a CAGR of approximately 4.2% during the forecast period.

What segments are covered in this report?

The South & Central America Feed Anticoccidials Market report typically cover these key segments- 类型（离子载体、化学抗球虫药和化学离子载体）形态（干态和液态）牲畜（家禽、反刍动物、猪等）

What is the historic period, base year, and forecast period taken for South & Central America Feed Anticoccidials Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Feed Anticoccidials Market report: 2025-2031 2023 2021-2023

Who are the major players in South & Central America Feed Anticoccidials Market?

The South & Central America Feed Anticoccidials Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Phibro Animal Health Corp ; Zoetis Inc ; Kemin Industries Inc ; Elanco Animal Health Inc ; Huvepharma EOOD ; Impextraco NV ; Virbac SA.

Who should buy this report?

The South & Central America Feed Anticoccidials Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the South & Central America Feed Anticoccidials Market value chain can benefit from the information contained in a comprehensive market report.

南美和中美饲料抗球虫药市场（主要地区、市场参与者、规模和份额）- 预测至 2031 年

2023 年，南美和中美饲料抗球虫药市场价值为 1.7663 亿美元，预计到 2031 年将达到 2.4571 亿美元；预计 2023 年至 2031 年的复合年增长率为 4.2%。

动物饲料中非离子载体的引入南美和中美饲料抗球虫药市场

离子载体具有一定程度的抗菌活性，符合抗生素的传统定义。所有离子载体都被批准用于肉鸡生产，但并非所有离子载体都被批准或对火鸡都是安全的。盐霉素和甲基萘甲醚对火鸡和马有相当大的毒性。由于离子载体是抗生素，因此不应连续使用，而应与不同的抗球虫药轮换使用。此外，对在饲料中使用抗生素作为添加剂有严格的规定。因此，制造商正在开发各种不能称为抗生素的抗球虫药。

非离子载体抗球虫药是通过化学合成的化合物，因此属于化学抗球虫药类别。它们通过杀灭活性消灭球虫，或通过静息活性抑制球虫。它们没有已知的抗菌活性，因此不被视为抗生素。非离子载体抗球虫药含有尼卡巴嗪、唑来膦酸、氨丙啉、氯吡醇、癸氧喹酯、罗贝尼定和地克珠利。EW Nutrition 是一家农业综合企业，致力于创造可靠的解决方案，减少对抗生素的需求，尤其是在饲料中，该公司已开发出用于动物饲料的非离子载体抗球虫药。鉴于所有这些因素，担心在动物饲料中使用抗生素的畜牧养殖户可以选择非离子载体抗球虫药。因此，预计在预测期内，在动物饲料中引入非离子载体将为饲料抗球虫药市场带来丰厚的商机。

南美和中美饲料抗球虫药市场概览

巴西饲料抗球虫药市场受其庞大的畜牧业和不断增长的动物蛋白需求驱动。该国的家禽业严重依赖抗球虫药来预防和控制球虫病。巴西每年生产超过 11.79 公吨鸡肉，其中约 3.62 公吨出口到 150 多个国家。截至 2023 年，该国的牛群数量约为 2.15 亿头，也增加了对饲料抗球虫药的需求。2022 年，巴西的牛肉产量达到 1050 万吨，其中出口约占 25%。

根据抗球虫药市场情况，离子载体抗球虫药占据主导地位，其次是化学抗球虫药。巴西农业、畜牧业和食品供应部 (MAPA) 监督的抗球虫药使用法规非常严格，在确保产品安全性和有效性的同时，还符合国际标准。该监管框架巩固了巴西作为值得信赖的全球动物蛋白产品供应商的地位。这些因素推动了巴西对饲料抗球虫药的需求。

南美和中美饲料抗球虫药市场收入及预测（2031 年）（百万美元）

南美和中美饲料抗球虫药市场细分

南美和中美饲料抗球虫药市场根据类型、形式、牲畜和国家进行细分。根据类型，南美和中美饲料抗球虫药市场分为离子载体、化学抗球虫药和化学离子载体。 2023 年，离子载体细分市场占有最大的市场份额。

就剂型而言，南美和中美饲料抗球虫药市场分为干剂和液剂。2023 年，干剂细分市场占有更大的市场份额。

根据牲畜，南美和中美饲料抗球虫药市场细分为家禽、反刍动物、猪和其他。2023 年，家禽细分市场占有最大的市场份额。

根据国家/地区，南美和中美饲料抗球虫药市场细分为巴西、阿根廷和南美和中美其他地区。2023 年，巴西占据了南美和中美饲料抗球虫药市场的主导地位。

Phibro Animal Health Corp、Zoetis Inc、Kemin Industries Inc、Elanco Animal Health Inc、Huvepharma EOOD、Impextraco NV 和 Virbac SA。是南美和中美饲料抗球虫药市场的一些领先企业。

South & Central America Feed Anticoccidials Strategic Insights

Strategic insights for South & Central America Feed Anticoccidials involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-feed-anticoccidials-market-strategic-framework.webp

Get more information on this report

South & Central America Feed Anticoccidials Report Scope

Report Attribute	Details
Market size in 2023	US$ 176.63 Million
Market Size by 2031	US$ 245.71 Million
Global CAGR (2023 - 2031)	4.2%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 类型（离子载体、化学抗球虫药和化学离子载体） By 形态（干态和液态） By 牲畜（家禽、反刍动物、猪等）
Regions and Countries Covered	南美洲和中美洲（巴西、阿根廷、南美洲和中美洲其他地区）南美洲和中美洲（巴西、阿根廷、南美洲和中美洲其他地区）
Market leaders and key company profiles	Phibro Animal Health Corp Zoetis Inc Kemin Industries Inc Elanco Animal Health Inc Huvepharma EOOD Impextraco NV Virbac SA.

Get more information on this report

South & Central America Feed Anticoccidials Regional Insights

The regional scope of South & Central America Feed Anticoccidials refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.